{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:00:54Z","timestamp":1792497654808,"version":"4.5.0"},"reference-count":23,"publisher":"The Company of Biologists","issue":"20","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>For researchers and clinician-scientists, forging partnerships with patient-led rare disease organizations can be a challenge. Patient-led rare disease organizations often operate quite differently to research and medical institutions, large private or public funding organizations, and pharmaceutical or biotechnology companies, leaving researchers and clinician-scientists uncertain about how, when and where to engage for mutual benefit. However, the value of reciprocal engagement can be immense, paying dividends in new research directions, accelerating existing research, facilitating access to funding and achieving success in translation. Most importantly, it can improve the lives of individuals with disease. In this Perspective, we will explore the value of engaging and collaborating with patient-led rare disease organizations through the lens of a rare syndromic ciliopathy \u2013 Bardet\u2013Biedl syndrome (BBS) \u2013 for which patient-led organizations exist in multiple countries. We explain what researchers should know about how rare disease organizations operate, discuss examples of successful engagement between researchers, clinician-scientists and patient-led organizations, and review the \u2018do's and don't's\u2019 of successful collaboration.<\/jats:p>","DOI":"10.1242\/jcs.264320","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:35:33Z","timestamp":1761557733000},"source":"Crossref","is-referenced-by-count":3,"title":["Engaging patient-led rare disease organizations to advance research \u2013 through the lens of Bardet\u2013Biedl syndrome"],"prefix":"10.1242","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2404-7813","authenticated-orcid":false,"given":"Timothy","family":"Ogden","sequence":"first","affiliation":[{"name":"BBS Foundation 1 , PO Box 663 Unionville, PA 19375 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendert","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Bardet Biedl Syndroom Stichting 2 , Keulvoet 12, 8266KK Kampen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia","family":"Hymers","sequence":"additional","affiliation":[{"name":"BBS UK 3 , 43 Balton Way, Dovercourt, Harwich, Essex, CO12 4UP ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2025102705352812200_JCS264320C1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nature02030","article-title":"Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome","volume":"425","author":"Ansley","year":"2003","journal-title":"Nature"},{"key":"2025102705352812200_JCS264320C2","unstructured":"Bardet, G.\n           (1920). Sur un syndrome d'ob\u00e9sit\u00e9 infantile avec polydactylie et r\u00e9tinite pigmentaire. (Contribution a l'\u00e9tude des formes cliniques de l'ob\u00e9sit\u00e9 hypophysaire). Th\u00e8se de Paris, 1920, No 479."},{"key":"2025102705352812200_JCS264320C3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jmg.36.6.437","article-title":"New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey","volume":"36","author":"Beales","year":"1999","journal-title":"J. Med. Genet."},{"key":"2025102705352812200_JCS264320C4","first-page":"1630","article-title":"Ein Geschwisterpaar mit adiposo-genitaler Dystrophie","volume":"48","author":"Biedl","year":"1922","journal-title":"Deutsche Med. Wochenschr."},{"key":"2025102705352812200_JCS264320C5","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/cimb46030163","article-title":"Autosomal recessive rod-cone dystrophy with mild extra-ocular manifestations due to a splice-affecting variant in BBS9","volume":"46","author":"Deitch","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"2025102705352812200_JCS264320C6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1399-0004.1989.tb03378.x","article-title":"High incidence of Bardet Biedl syndrome among the Bedouin","volume":"36","author":"Farag","year":"1989","journal-title":"Clin. Genet."},{"key":"2025102705352812200_JCS264320C7","doi-asserted-by":"publisher","first-page":"Unit 10.11","DOI":"10.1002\/0471142905.hg1011s57","article-title":"The catalogue of somatic mutations in cancer (COSMIC)","volume":"Chapter 10","author":"Forbes","year":"2008","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"2025102705352812200_JCS264320C8","first-page":"1993","article-title":"Bardet-Biedl Syndrome Overview. 2003 Jul 14 [updated 2023 Mar 23]","volume-title":"GeneReviews\u00ae","author":"Forsyth","year":"2003"},{"key":"2025102705352812200_JCS264320C9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"2025102705352812200_JCS264320C10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fped.2018.00023","article-title":"Managing Bardet-Biedl Syndrome-Now and in the Future","volume":"6","author":"Forsythe","year":"2018","journal-title":"Front. Pediatr."},{"key":"2025102705352812200_JCS264320C11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.omtn.2022.12.007","article-title":"Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model","volume":"31","author":"Hsu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2025102705352812200_JCS264320C12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cell.2010.05.015","article-title":"The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to cilia","volume":"141","author":"Jin","year":"2010","journal-title":"Cell"},{"key":"2025102705352812200_JCS264320C13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/79201","article-title":"Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome","volume":"26","author":"Katsanis","year":"2000","journal-title":"Nat. Genet."},{"key":"2025102705352812200_JCS264320C14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ng1418","article-title":"Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse","volume":"36","author":"Kulaga","year":"2004","journal-title":"Nat. Genet."},{"key":"2025102705352812200_JCS264320C15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ng1293-392","article-title":"Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity","volume":"5","author":"Kwitek-Black","year":"1993","journal-title":"Nat. Genet."},{"key":"2025102705352812200_JCS264320C16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.devcel.2008.11.001","article-title":"A BBSome subunit links ciliogenesis, microtubule stability, and acetylation","volume":"15","author":"Loktev","year":"2008","journal-title":"Dev. Cell"},{"key":"2025102705352812200_JCS264320C17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ajmg.a.30406","article-title":"Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study","volume":"132A","author":"Moore","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"2025102705352812200_JCS264320C18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"2025102705352812200_JCS264320C19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2007.03.053","article-title":"A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis","volume":"129","author":"Nachury","year":"2007","journal-title":"Cell"},{"key":"2025102705352812200_JCS264320C20","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/humu.23862","article-title":"Meta-analysis of genotype-phenotype associations in Bardet-Biedl syndrome uncovers differences among causative genes","volume":"40","author":"Niederlova","year":"2019","journal-title":"Hum. Mutat."},{"key":"2025102705352812200_JCS264320C21","doi-asserted-by":"publisher","first-page":"1549310","DOI":"10.3389\/fendo.2025.1549310","article-title":"Developing a congenital hyperinsulinism prioritized research agenda: a patient-driven international collaborative research network","volume":"16","author":"Pasquini","year":"2025","journal-title":"Front. Endocrinol."},{"key":"2025102705352812200_JCS264320C22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-025-03641-3","article-title":"Clinical and genetic aspects of Bardet\u2013Biedl syndrome in adults in Norway","volume":"20","author":"Rustad","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"2025102705352812200_JCS264320C23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/79116","article-title":"Mutations in MKKS cause Bardet-Biedl syndrome","volume":"26","author":"Slavotinek","year":"2000","journal-title":"Nat. Genet."}],"container-title":["Journal of Cell Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/jcs\/article-pdf\/doi\/10.1242\/jcs.264320\/3670731\/jcs264320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/jcs\/article-pdf\/doi\/10.1242\/jcs.264320\/3670731\/jcs264320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:35:35Z","timestamp":1761557735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/jcs\/article\/138\/20\/jcs264320\/369629\/Engaging-patient-led-rare-disease-organizations-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,10,15]]}},"URL":"https:\/\/doi.org\/10.1242\/jcs.264320","relation":{},"ISSN":["0021-9533","1477-9137"],"issn-type":[{"value":"0021-9533","type":"print"},{"value":"1477-9137","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"jcs264320"}}